Target intelligence / Profile preview

TBC1 domain family member 5 (TBC1D5)

Target
TBC1D5
Molecular classification
Enzyme (specifically, Rab GTPase-activating protein), Other (Retromer accessory/regulatory protein)
01

Overview

TBC1 domain family member 5 (TBC1D5) is an enzyme belonging to the TBC (Tre-2/Bub2/Cdc16) domain-containing protein family, functioning as a GTPase-activating protein (GAP) for Rab7, an essential regulator of intracellular membrane trafficking. TBC1D5 acts as a key accessory and regulatory protein for the retromer complex, where it negatively regulates retromer function by promoting Rab7 GTP hydrolysis and thus controlling the dissociation of membrane-associated retromer. Loss or knockdown of TBC1D5 leads to enhanced activation of Rab7 and promotes retromer-mediated trafficking of proteins from endosomes to the Golgi and plasma membrane. TBC1D5 interacts tightly and specifically with the core subunits of the retromer complex (mainly VPS29 and VPS35), and this interaction plays a fundamental role in endosome dynamics, protein sorting, and cellular homeostasis. Dysregulation of TBC1D5, retromer function, or associated sorting mechanisms is implicated in diseases such as neurodegeneration, notably Alzheimer’s disease, due to impacts on trafficking and amyloid precursor protein processing[1][2][3]. There are no currently known drugs targeting TBC1D5 directly, and it is not yet a druggable target, but it is an active subject of basic research for understanding trafficking diseases and therapeutic strategies.

Other names
KIAA0210TBC1D5
02

Biological functions

Regulation of endosomal traffickingRegulation of retromer-mediated endosome-to-Golgi and endosome-to-plasma membrane traffickingControl of Rab7 GTPase activityProtein sorting in endosomesRegulation of autophagy
03

Disease associations

Neurodegenerative diseaseOther (Implicated in endosome protein sorting defects, potentially relevant to Alzheimer’s)
04

Safety considerations

Potential off-target effects on endosomal trafficking if manipulatedAltered protein sorting and potential effects on autophagy or neurodegeneration

Beyond the preview

Go deeper on TBC1 domain family member 5 (TBC1D5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TBC1 domain family member 5 (TBC1D5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call